Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

The Challenging Experience Questionnaire: Characterization of challenging experiences with psilocybin mushrooms
Frederick S. Barrett, Matthew P. Bradstreet, Jeannie‐Marie Leoutsakos, et al.
Journal of Psychopharmacology (2016) Vol. 30, Iss. 12, pp. 1279-1295
Open Access | Times Cited: 263

Showing 1-25 of 263 citing articles:

Quality of Acute Psychedelic Experience Predicts Therapeutic Efficacy of Psilocybin for Treatment-Resistant Depression
Leor Roseman, David Nutt, Robin Carhart‐Harris
Frontiers in Pharmacology (2018) Vol. 8
Open Access | Times Cited: 636
Serotonin and brain function: a tale of two receptors
RL Carhart-Harris, DJ Nutt
Journal of Psychopharmacology (2017) Vol. 31, Iss. 9, pp. 1091-1120
Open Access | Times Cited: 593
Psychedelics and the essential importance of context
Robin Carhart‐Harris, Leor Roseman, Eline Haijen, et al.
Journal of Psychopharmacology (2018) Vol. 32, Iss. 7, pp. 725-731
Closed Access | Times Cited: 504
Predicting Responses to Psychedelics: A Prospective Study
Eline Haijen, Mendel Kaelen, Leor Roseman, et al.
Frontiers in Pharmacology (2018) Vol. 9
Open Access | Times Cited: 317
Emotional breakthrough and psychedelics: Validation of the Emotional Breakthrough Inventory
Leor Roseman, Eline Haijen, Kelvin Idialu-Ikato, et al.
Journal of Psychopharmacology (2019) Vol. 33, Iss. 9, pp. 1076-1087
Closed Access | Times Cited: 290
Psychological flexibility mediates the relations between acute psychedelic effects and subjective decreases in depression and anxiety
Alan K. Davis, Frederick S. Barrett, Roland R. Griffiths
Journal of Contextual Behavioral Science (2019) Vol. 15, pp. 39-45
Open Access | Times Cited: 281
Long-term follow-up of psilocybin-assisted psychotherapy for psychiatric and existential distress in patients with life-threatening cancer
Gabrielle Agin-Liebes, Tara C. Malone, Matthew M. Yalch, et al.
Journal of Psychopharmacology (2020) Vol. 34, Iss. 2, pp. 155-166
Closed Access | Times Cited: 262
Survey of subjective "God encounter experiences": Comparisons among naturally occurring experiences and those occasioned by the classic psychedelics psilocybin, LSD, ayahuasca, or DMT
Roland R. Griffiths, Ethan Hurwitz, Alan K. Davis, et al.
PLoS ONE (2019) Vol. 14, Iss. 4, pp. e0214377-e0214377
Open Access | Times Cited: 205
Psilocybin-assisted group therapy for demoralized older long-term AIDS survivor men: An open-label safety and feasibility pilot study
B. Anderson, Alicia Danforth, Prof Robert Daroff, et al.
EClinicalMedicine (2020) Vol. 27, pp. 100538-100538
Open Access | Times Cited: 202
The use of the psychological flexibility model to support psychedelic assisted therapy
Rosalind Watts, Jason B. Luoma
Journal of Contextual Behavioral Science (2019) Vol. 15, pp. 92-102
Closed Access | Times Cited: 189
Towards an understanding of psychedelic-induced neuroplasticity
Abigail E. Calder, Gregor Hasler
Neuropsychopharmacology (2022) Vol. 48, Iss. 1, pp. 104-112
Open Access | Times Cited: 177
Psychedelic Treatments for Psychiatric Disorders: A Systematic Review and Thematic Synthesis of Patient Experiences in Qualitative Studies
Joost J. Breeksema, Alistair Niemeijer, Erwin Krediet, et al.
CNS Drugs (2020) Vol. 34, Iss. 9, pp. 925-946
Open Access | Times Cited: 166
Psilocybin acutely alters the functional connectivity of the claustrum with brain networks that support perception, memory, and attention
Frederick S. Barrett, Samuel R. Krimmel, Roland R. Griffiths, et al.
NeuroImage (2020) Vol. 218, pp. 116980-116980
Open Access | Times Cited: 147
Psychedelic Communitas: Intersubjective Experience During Psychedelic Group Sessions Predicts Enduring Changes in Psychological Wellbeing and Social Connectedness
Hannes Kettner, Fernando E. Rosas, Christopher Timmermann, et al.
Frontiers in Pharmacology (2021) Vol. 12
Open Access | Times Cited: 143
Learning to Let Go: A Cognitive-Behavioral Model of How Psychedelic Therapy Promotes Acceptance
Max Wolff, Ricarda Evens, Lea J. Mertens, et al.
Frontiers in Psychiatry (2020) Vol. 11
Open Access | Times Cited: 139
Development of the Psychological Insight Questionnaire among a sample of people who have consumed psilocybin or LSD
Alan K. Davis, Frederick S. Barrett, Sara So, et al.
Journal of Psychopharmacology (2021) Vol. 35, Iss. 4, pp. 437-446
Open Access | Times Cited: 129
Adverse events in clinical treatments with serotonergic psychedelics and MDMA: A mixed-methods systematic review
Joost J. Breeksema, Bouwe Kuin, Jeanine Kamphuis, et al.
Journal of Psychopharmacology (2022) Vol. 36, Iss. 10, pp. 1100-1117
Open Access | Times Cited: 126
Validation of the Psychological Insight Scale: A new scale to assess psychological insight following a psychedelic experience
Joseph Peill, Katie Trinci, Hannes Kettner, et al.
Journal of Psychopharmacology (2022) Vol. 36, Iss. 1, pp. 31-45
Open Access | Times Cited: 102
Psilocybin-assisted therapy for major depressive disorder: An exploratory placebo-controlled, fixed-order trial
Jordan Sloshower, Patrick D. Skosnik, Hamideh Safi-Aghdam, et al.
Journal of Psychopharmacology (2023) Vol. 37, Iss. 7, pp. 698-706
Closed Access | Times Cited: 84
Prevalence and associations of challenging, difficult or distressing experiences using classic psychedelics
Otto Simonsson, Peter S. Hendricks, Richard Chambers, et al.
Journal of Affective Disorders (2023) Vol. 326, pp. 105-110
Open Access | Times Cited: 69
Extended difficulties following the use of psychedelic drugs: A mixed methods study
Jules Evans, Oliver Robinson, Eirini K. Argyri, et al.
PLoS ONE (2023) Vol. 18, Iss. 10, pp. e0293349-e0293349
Open Access | Times Cited: 61
History repeating: guidelines to address common problems in psychedelic science
Michiel van Elk, Eiko I. Fried
Therapeutic Advances in Psychopharmacology (2023) Vol. 13
Open Access | Times Cited: 51
Case analysis of long-term negative psychological responses to psychedelics
Rebecka Bremler, Nancy Katati, Parvinder Shergill, et al.
Scientific Reports (2023) Vol. 13, Iss. 1
Open Access | Times Cited: 42
Naturalistic psilocybin use is associated with persisting improvements in mental health and wellbeing: results from a prospective, longitudinal survey
Sandeep M. Nayak, Hillary Jackson, Nathan D. Sepeda, et al.
Frontiers in Psychiatry (2023) Vol. 14
Open Access | Times Cited: 40
Acute Adverse Effects of Therapeutic Doses of Psilocybin
Akhila Yerubandi, Jennifer E. Thomas, N. M. Mahmudul Alam Bhuiya, et al.
JAMA Network Open (2024) Vol. 7, Iss. 4, pp. e245960-e245960
Open Access | Times Cited: 19
Page 1 - Next Page

Scroll to top